Similar articles for PMID: 9206551

Year	Number of Results
1990	1
1994	6
1995	3
1996	7
1997	7
1998	14
1999	13
2000	8
2001	8
2002	5
2003	8
2004	1
2005	3
2006	2
2007	1
2008	1
2009	4
2010	2
2011	3
2012	2
2013	3
2014	2
2015	2
2016	3
2017	7
2018	2
2019	1
2020	1
2024	0

1

[HIV and pregnancy: risks of transmission and therapeutic possibilities].

Ibe M, Knolle P, Beck T, Meyer zum Büschenfelde KH, Gerken G. Ibe M, et al. Gynakol Geburtshilfliche Rundsch. 1996;36(4):188-93. doi: 10.1159/000272661. Gynakol Geburtshilfliche Rundsch. 1996. PMID: 9206551 Review. German.

2

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

Kesho Bora Study Group; de Vincenzi I. Kesho Bora Study Group, et al. Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Lancet Infect Dis. 2011. PMID: 21237718 Clinical Trial.

3

[Reducing perinatal transmission by antiretroviral therapy].

Schmied B. Schmied B. Wien Med Wochenschr. 1998;148(23-24):550-5. Wien Med Wochenschr. 1998. PMID: 10189685 Review. German.

4

Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone.

Simpson BJ, Shapiro ED, Andiman WA. Simpson BJ, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):145-52. doi: 10.1097/00042560-199702010-00007. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9052723

5

Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.

Kowalska A, Niemiec T, El Midaoui A, Burkacka E. Kowalska A, et al. Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):459-68. Med Wieku Rozwoj. 2003. PMID: 15010556 Clinical Trial.

6

No adverse effects in infants following short-course zidovudine.

[No authors listed] [No authors listed] AIDS Read. 2001 Feb;11(2):81. AIDS Read. 2001. PMID: 11279877 No abstract available.

7

15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group.

[No authors listed] [No authors listed] Lancet. 1999 Dec 11;354(9195):2050-1. Lancet. 1999. PMID: 10636375 Clinical Trial.

8

Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.

Short CE, Douglas M, Smith JH, Taylor GP. Short CE, et al. HIV Med. 2014 Apr;15(4):233-8. doi: 10.1111/hiv.12083. Epub 2013 Sep 11. HIV Med. 2014. PMID: 24025074 Free article.

9

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al. Connor EM, et al. N Engl J Med. 1994 Nov 3;331(18):1173-80. doi: 10.1056/NEJM199411033311801. N Engl J Med. 1994. PMID: 7935654 Free article. Clinical Trial.

10

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ. Mofenson LM, et al. N Engl J Med. 1999 Aug 5;341(6):385-93. doi: 10.1056/NEJM199908053410601. N Engl J Med. 1999. PMID: 10432323 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

117 results

Results by year